Williams Paul Anthony — SEC Form 4 filings
SEC reporting owner CIK 1961994. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-27 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 7,000 shares, $58,960 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 4,000 shares @ $8.44 ($33,760) in Emergent BioSolutions Inc., filed 2026-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | SVP, Products Business | 15 | — | 2 legs · 7,000 sh · $58,960 | 18 |
Form 4 filings — Williams Paul Anthony
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Emergent BioSolutions Inc. (EBS) | Sale (S): 3,000 @ $8.40 | EDGAR |
| 2026-06-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 694 @ $8 | EDGAR |
| 2026-05-01 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 100,111 @ $0 | EDGAR |
| 2026-04-03 | 4 | Emergent BioSolutions Inc. (EBS) | Sale (S): 4,000 @ $8.44 | EDGAR |
| 2026-03-05 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 9,397 @ $8.44 · Grant/award (A): 44,834 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 116 @ $8.15 | EDGAR |
| 2026-02-10 | 4 | Emergent BioSolutions Inc. (EBS) | Disposition to issuer (D): 8,655 @ $10.92 · Tax withholding (F): 1,022 @ $10.92 | EDGAR |
| 2025-06-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 464 @ $6.63 | EDGAR |
| 2025-03-10 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 382 @ $7.48 · Tax withholding (F): 116 @ $7.48 | EDGAR |
| 2024-07-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 85 @ $8.13 | EDGAR |
| 2024-06-11 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 464 @ $6.19 | EDGAR |
| 2024-03-15 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 450 @ $3.23 · Tax withholding (F): 137 @ $3.39 | EDGAR |
| 2024-02-27 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 105 @ $2.74 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1961994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →